Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Cornu

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Fundamental & Clinical Pharmacology|May 25, 2005
Impact of French 'Comités de Protection des Personnes' on the readability of informed consent documents (ICD) in biomedical research: more information, but not better informationAdeline Paris, Jean-Luc Cracowski, Patrick Maison, et al.
Therapie|November 16, 2021
Reappraisal of the efficacy of intensive glycaemic control on microvascular complications in patients with type 2 diabetes: A meta-analysis of randomised control-trialsSophie Sun, Lucie Hisland, Guillaume Grenet, et al.
Therapie|December 20, 2003
[Preventing dependency in elderly persons: randomized study in the community]Catherine Cornu, Corinne Carré, Gilles Guetemme, et al.
Drug Testing and Analysis|March 28, 2020
Low doses of recombinant human erythropoietin does not affect C-terminal FGF23 in healthy menJacob Bejder, Paul Robach, Anne-Kristine Lundby, et al.
Journal of Clinical Epidemiology|July 13, 2015
Different treatment benefits were estimated by clinical trials performed in adults compared with those performed in childrenPerrine Janiaud, Audrey Lajoinie, Fleur Cour-Andlauer, et al.
Therapie|December 18, 2012
Farnesoid X receptor targeting for hepatitis C: study protocol for a proof-of-concept trialCaroline Scholtes, Patrice André, Christian Trépo, et al.
BMC Medical Research Methodology|November 16, 2013
Are concomitant treatments confounding factors in randomized controlled trials on intensive blood-glucose control in type 2 diabetes? a systematic reviewRémy Boussageon, Irène Supper, Sylvie Erpeldinger, et al.
Transplantation Research|July 23, 2013
Efficacy and safety of concentration-controlled everolimus with reduced-dose cyclosporine in Japanese de novo renal transplant patients: 12-month resultsKota Takahashi, Kazuharu Uchida, Norio Yoshimura, et al.
Trials|April 9, 2013
Revising the ECRIN standard requirements for information technology and data management in clinical trialsChristian Ohmann, Steve Canham, Catherine Cornu, et al.
Endocrine Connections|August 3, 2021
Reference values for IGF-I serum concentration in an adult population: use of the VARIETE cohort for two new immunoassaysNadia Sabbah, Peter Wolf, Céline Piedvache, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Fundamental & Clinical Pharmacology|May 25, 2005
Impact of French 'Comités de Protection des Personnes' on the readability of informed consent documents (ICD) in biomedical research: more information, but not better informationAdeline Paris, Jean-Luc Cracowski, Patrick Maison, et al.
Therapie|November 16, 2021
Reappraisal of the efficacy of intensive glycaemic control on microvascular complications in patients with type 2 diabetes: A meta-analysis of randomised control-trialsSophie Sun, Lucie Hisland, Guillaume Grenet, et al.
Therapie|December 20, 2003
[Preventing dependency in elderly persons: randomized study in the community]Catherine Cornu, Corinne Carré, Gilles Guetemme, et al.
Drug Testing and Analysis|March 28, 2020
Low doses of recombinant human erythropoietin does not affect C-terminal FGF23 in healthy menJacob Bejder, Paul Robach, Anne-Kristine Lundby, et al.
Journal of Clinical Epidemiology|July 13, 2015
Different treatment benefits were estimated by clinical trials performed in adults compared with those performed in childrenPerrine Janiaud, Audrey Lajoinie, Fleur Cour-Andlauer, et al.
Therapie|December 18, 2012
Farnesoid X receptor targeting for hepatitis C: study protocol for a proof-of-concept trialCaroline Scholtes, Patrice André, Christian Trépo, et al.
BMC Medical Research Methodology|November 16, 2013
Are concomitant treatments confounding factors in randomized controlled trials on intensive blood-glucose control in type 2 diabetes? a systematic reviewRémy Boussageon, Irène Supper, Sylvie Erpeldinger, et al.
Transplantation Research|July 23, 2013
Efficacy and safety of concentration-controlled everolimus with reduced-dose cyclosporine in Japanese de novo renal transplant patients: 12-month resultsKota Takahashi, Kazuharu Uchida, Norio Yoshimura, et al.
Trials|April 9, 2013
Revising the ECRIN standard requirements for information technology and data management in clinical trialsChristian Ohmann, Steve Canham, Catherine Cornu, et al.
Endocrine Connections|August 3, 2021
Reference values for IGF-I serum concentration in an adult population: use of the VARIETE cohort for two new immunoassaysNadia Sabbah, Peter Wolf, Céline Piedvache, et al.
Pageof 9